ProMIS Neurosciences, Inc. (PMN) Reports In-Line Q3 EPS

ProMIS Neurosciences, Inc. (NASDAQ: PMN) reported Q3 EPS of ($0.24), in-line with the analyst estimate of ($0.24).

For earnings history and earnings-related data on ProMIS Neurosciences, Inc. (PMN) click here.

You May Also Be Interested In

• Domino's Pizza (DPZ) Misses Q2 EPS by 12c, Beats on Revenue
• Organigram reports Sanity unit at ~10% German market share
• Boeing 737 MAX 7 and 10 certification expected soon, FAA official says